The primary end point (a composite of cardiovascular death, myocardial infarction, or ischemic stroke) occurred in 613 patients in the saxagliptin group and in 609 patients in the placebo group (7.3 and 7.2%), which was not significantly different
One key difference: tirzepatide is a dual GIP/GLP-1 receptor agonist, while semaglutide targets only GLP-1
Eat Yourself Smart: 10 Foods That Can Destroy Your Brain & How To Fuel Your Brain With The Best Cognitive-Boosting Alternatives
Husk ogs sjekke RTP p spillene, siden hyere tilbakebetalingsprosent kan gi bedre sjanser til omsette bonusen i tide
Frias JP, Wynne AG, Matyjaszek-Matuszek B, Bartaskova D, Cox DA, Woodward B, et al